Jon Symonds News
Most Popular Jon Symonds Story
Goldman readies investment pool for drug R&D
Goldman Sachs says it is ready to start funneling hundreds of millions of dollars into a new 'hybrid' R&D model that will be used to advance early and mid-stage drugs in the biopharma pipeline. Read more...
Latest Headlines
- December 3, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
